Use of vascular endothelial growth factor to treat photoreceptor cells
US7045496B1 · kind B1 · utility
0Cited by
20References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2000 |
| Grant date | May 16, 2006 |
| Priority date | — |
| Expiry date | Feb 7, 2020 |
Classification
- Technology area (CPC —)General
Abstract
The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.